HumacyteHUMA

那斯達克 · USD
1.34
-0.05
(-3.60%)
收盤 06/11 03:59 (UTC+8)
盤後 
1.19 
1.19 
(-11.19%)
06/11 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • 0.01
  • 0.00
  • 0.01
  • 0.00
  • 0.00
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -41.78
  • 150.17
  • -37.98
  • 6.00
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
495
467
753
301
517
-
-
-
-
-
營業成本
2,0389,082260213147-----
營業毛利
-1,543
-8,615
493
88
370
-
-
-
-
-
營業費用
27,39222,22124,88329,81523,554---26,57826,182
研發費用
19,46214,60517,27322,00615,41820,65622,92623,75321,26420,180
推銷及管理費用
7,9307,6167,6107,8098,1367,4327,3075,7465,3146,002
非經常性項目費用
----------
其他營業費用
----------
營業利益
-28,935
-30,836
-24,390
-29,727
-23,184
-28,088
-30,233
-29,499
-26,578
-26,182
其他收入及費用
13,5879,1259,492-5,38665,3239,656-6,531-24,649-3,5022,803
利息費用
2,2713,0932,6122,5453,0002,5082,4382,5151,8161,727
稅前純益
-17,619
-24,804
-17,510
-37,658
39,139
-20,940
-39,202
-56,663
-31,896
-25,106
所得稅
----------
稅後純益
-17,619
-24,804
-17,510
-37,658
39,139
-20,940
-39,202
-56,663
-31,896
-25,106
基本每股稅後盈餘(元)
-0.09-0.19-0.11-0.240.28-0.16-0.33-0.48-0.29-0.24
稀釋每股稅後盈餘(元)
-0.09-0.15-0.12-0.270.28-0.16-0.32-0.49-0.29-0.24
基本平均股數(千股)
197846.00187395.00158313.00155437.00131496.00126983.00119408.00119174.00108246.00103607.00
稀釋平均股數(千股)
197846.00187132.00158313.00155437.00131759.00126983.00119408.00119174.00108246.00103607.00
還原基本每股稅後盈餘(元)
-0.09-0.19-0.11-0.240.28-0.16-0.33-0.48-0.29-0.24
還原稀釋每股稅後盈餘(元)
-0.09-0.15-0.12-0.270.28-0.16-0.32-0.49-0.29-0.24
還原基本平均股數(千股)
197,846187,395158,313155,437131,496126,983119,408119,174108,246103,607
還原稀釋平均股數(千股)
197,846187,132158,313155,437131,759126,983119,408119,174108,246103,607
EBITDA(千元)
-13,276-19,923-13,033-33,25343,971-16,624-34,952-52,369-28,289-21,546

大家都在看

HOT